MAYNF (Mayne Pharma Group) Land And Improvements: $19.4 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MAYNF Mayne Pharma Group Ltd MAYNF
68 GF Score
Price $2.35
GF Value $2.82
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Mayne Pharma Group Land And Improvements?

Mayne Pharma Group MAYNF 68 Land And Improvements is $19.4 Mil as of Jun. 2026. GuruFocus rates MAYNF with a GF Score™ of 68/100 and a GF Value™ of $2.82 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Mayne Pharma Group's land and improvements for the quarter that ended in Jun. 2026 was $19.4 Mil.

Mayne Pharma Group's quarterly land and improvements declined from Jun. 2025 ($14.9 Mil) to Dec. 2025 ($0.0 Mil) but then increased from Dec. 2025 ($0.0 Mil) to Jun. 2026 ($19.4 Mil).

Mayne Pharma Group's annual land and improvements declined from Jun. 2024 ($15.2 Mil) to Jun. 2025 ($14.9 Mil) but then increased from Jun. 2025 ($14.9 Mil) to Jun. 2026 ($19.4 Mil).

Mayne Pharma Group Land And Improvements Historical Data

* Premium members only.

The historical data trend for Mayne Pharma Group's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mayne Pharma Group Land And Improvements Chart

Mayne Pharma Group Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Land And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only 96.31 15.37 15.21 14.91 19.38

Mayne Pharma Group Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Land And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.21 0.00 14.91 0.00 19.38
MAYNF
68GF Score
Mayne Pharma Group Ltd MAYNF
Land And Improvements is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mayne Pharma Group Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Frequently Asked Questions Learn more about Land And Improvements →
What does a Land And Improvements of $19.4 Mil mean?
Mayne Pharma Group (MAYNF) has a Land And Improvements of $19.4 Mil as of Jun. 2026. Land and improvements records the total value of a company's land and improvements to it. View historical data on Mayne Pharma Group and its competitors.
Is Mayne Pharma Group's Land And Improvements too high?
Mayne Pharma Group's current Land And Improvements is $19.4 Mil. Overall, Mayne Pharma Group has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mayne Pharma Group's Land And Improvements compare to MCK and COR?
Mayne Pharma Group's Land And Improvements of $19.4 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Land And Improvements for a Medical Distribution company?
A good Land And Improvements depends on the Medical Distribution industry context. However, Land And Improvements should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Land And Improvements mean?
A high Land And Improvements can signal that a stock is expensive relative to its fundamentals. Land and improvements records the total value of a company's land and improvements to it. View historical data on Mayne Pharma Group and its competitors. Mayne Pharma Group's current Land And Improvements is $19.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mayne Pharma Group stock overvalued right now?
Based on GuruFocus' analysis, Mayne Pharma Group (MAYNF) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.82, compared to a current price of $2.35 — trading 16.7% below its estimated fair value. The current Land And Improvements is $19.4 Mil. Mayne Pharma Group's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Land And Improvements calculated?
Land And Improvements is calculated from a company's financial statements. For Mayne Pharma Group (MAYNF), the current Land And Improvements is $19.4 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mayne Pharma Group (MAYNF) Overvalued in 2026?

Based on GuruFocus' analysis, Mayne Pharma Group stock appears to be undervalued. The current stock price of $2.35 is trading 16.7% below its estimated GF Value™ of $2.82. GuruFocus considers Mayne Pharma Group to be Modestly Undervalued.

Key valuation signals for MAYNF:

  • Land And Improvements: $19.4 Mil
  • GF Value™: $2.82 vs. price of $2.35 (16.7% below fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the MAYNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mayne Pharma Group Business Description

Other Exchanges MYX:Australia
Address 1538 Main North Road, Salisbury South, Salisbury, SA, AUS, 5106
Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Women's Health and Dermatology. The Dermatologysegment distributes dermatology products (branded and generic) in the U.S. on a portfolio basis, The Women's Health segment distributes branded women's health products in the U.S. International's segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.
68GF Score

Get the complete analysis for MAYNF

Land And Improvements is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.35
Price
$2.82
GF Value